NADAC acquisition cost data for EMVERM 100 MG TABLET CHEW. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 64896066930 | $538.55 | 2022-02-01 | Rx |
| 64896066930 | $538.55 | 2022-02-01 | Rx |
| 64896066930 | $538.55 | 2022-02-01 | Rx |
| 64896066930 | $538.55 | 2022-02-01 | Rx |
| 64896066930 | $538.55 | 2022-02-01 | Rx |
| 64896066930 | $538.55 | 2022-02-01 | Rx |
| 64896066930 | $538.55 | 2022-02-01 | Rx |
| 64896066930 | $538.55 | 2022-02-01 | Rx |
| 64896066930 | $538.55 | 2022-02-01 | Rx |
| 64896066930 | $538.55 | 2022-02-01 | Rx |
Generic: Mebendazole | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $3.2M | 1,579 | 1,221 | $429.87 |
| 2020 | $3.4M | 1,572 | 1,241 | $467.76 |
| 2021 | $3.4M | 1,367 | 1,063 | $519.78 |
| 2022 | $3.5M | 1,308 | 1,039 | $584.08 |
| 2023 | $5.0M | 1,577 | 1,226 | $643.03 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| California | $585.0K | 180 | 139 |
| Florida | $522.5K | 172 | 147 |
| New Mexico | $457.7K | 32 | N/A |
| New York | $350.7K | 115 | 88 |
| Texas | $342.5K | 117 | 97 |
| Oregon | $180.6K | 11 | N/A |
| Pennsylvania | $174.5K | 53 | 44 |
| Kentucky | $153.0K | 64 | 50 |
| Georgia | $148.1K | 41 | 39 |
| North Carolina | $145.8K | 60 | 44 |
| Ohio | $141.7K | 61 | 54 |
| Massachusetts | $124.1K | 36 | 23 |
| Illinois | $113.5K | 45 | 39 |
| Michigan | $104.8K | 41 | 31 |
| South Carolina | $104.6K | 35 | 30 |
| Nevada | $100.9K | 27 | 13 |
| Alabama | $94.7K | 30 | 23 |
| Tennessee | $81.5K | 23 | 22 |
| New Jersey | $78.5K | 27 | 22 |
| Oklahoma | $78.3K | 26 | 19 |
| Maryland | $74.5K | 31 | 20 |
| Missouri | $64.4K | 29 | 23 |
| Arizona | $61.9K | 21 | 17 |
| Washington | $60.9K | 24 | 15 |
| Arkansas | $58.6K | 32 | 16 |
| Utah | $56.3K | 13 | N/A |
| Louisiana | $52.9K | 22 | 18 |
| West Virginia | $51.8K | 28 | 23 |
| Virginia | $47.9K | 19 | 16 |
| Connecticut | $47.6K | 15 | 13 |
| Iowa | $46.9K | 17 | 14 |
| Mississippi | $44.7K | 18 | 17 |
| Indiana | $41.5K | 15 | 12 |
| Maine | $39.6K | 16 | N/A |
| Kansas | $38.4K | 12 | 11 |
| Wisconsin | $28.0K | 15 | 14 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.